IPO

Clairvest's successful exit from F12.net yields a 35% IRR, showcasing a powerful growth strategy for private equity in Canada's booming MSP market.

Jiuzi Holdings announced a $4M offering, tanking its stock. Then, news of a $1B crypto funding plan sent it soaring. A deep dive into a high-stakes pivot.

A top Forbes ranking is impressive, but HealthWell Foundation's 100% fundraising efficiency reveals a new benchmark for non-profit impact. Here's how.

Sidus Space CEO Carol Craig's appointment to the Canaveral Port Authority board signals a new era of synergy between Florida's sea and space industries.

A novel drug for alcohol use disorder gets key scientific backing. It promises the benefits of psychedelics with fewer risks, shaking up a $35B market.

Fresh off its IPO, iOThree is pushing AI and certified digital tools. Can its innovation engine and Asian expansion overcome market headwinds?

From electric cars to crypto custody, Jiuzi Holdings is chasing a $1B funding deal. A look at the massive risks and institutional hunger behind the pivot.

A $277M secondary offering sees MIAX shareholders cash in, but the company itself isn't taking any money. Here’s what that says about its financial power.

Serina Therapeutics poaches a top chemist to expand its POZ platform, signaling a major push beyond Parkinson's into new, high-value drug markets.

Brixton Metals secures nearly $10M in a complex financing deal. Here’s why this capital is a game-changer for its flagship Thorn copper-gold project.

Tenaya Therapeutics unveils promising interim data for its ARVC gene therapy, TN-401, hinting at a potential cure and igniting investor interest.

Tenaya Therapeutics seeks fresh capital to advance its heart disease pipeline, but the offering's structure raises dilution questions for investors.

Excelerate Energy signals deep confidence with a new $75M share buyback, balancing shareholder rewards with an ambitious global expansion in the LNG market.

Fast Track Group partners with CloudX to merge celebrity power with influencer trust. Can this hybrid model unlock profit in the complex APAC market?

First Trust unveils its new Dividend Aristocrats Target Income ETF in Europe, blending stable dividend stocks with a covered call strategy for yield-seekers.

With $150M from Crayhill Capital, Rostrum Pacific isn't just buying music history—it's building an integrated ecosystem to redefine its future.

With a new CEO, Menagerie Cellars is doubling down on its blend of luxury wine and conservation. Can this purpose-driven model scale in a tough market?

Lucid Software’s ‘Awardable’ status on a key DoD marketplace signals a shift in how national security projects are planned, secured, and executed.

Hong Kong's JM Group raised $15M in a wild NYSE debut. We look past the volatility to see what this IPO reveals about global supply chains and risk.

Cemtrex secures $2M for acquisitions, but a 15% stock drop and massive shareholder dilution reveal the high price of its ambitious growth strategy.